Dr. Peder Myhre: Welcome listeners to this week's issue of Circulation on the Run, the week of September 23. I am Dr. Peder ...
It can reveal plaque in arteries, offering a more precise estimate of a person’s risk of heart disease. Yet the test remains ...
The Food and Drug Administration cleared Heartflow's technology to quantify coronary plaque and the platform is now available, the company said.
Using magnetic cameras, researchers at Linköping University have examined blood flow in an artificial heart in real time. The ...
In TODAY.com's Expert Tip of the Day, a cardiologist reveals a common early symptom in patients with coronary artery disease.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
American Society of Nuclear Cardiology (ASNC), European Association of Nuclear Medicine (EANM), and American College of Nuclear Medicine (ACNM) have issued a new clinical guideline for 18F-flurpiridaz ...
Amgen’s next-generation cholesterol drug has shown it can reverse the build up of plaque build-up in coronary arteries which can lead to a heart attack or stroke. The company’s Repatha (evolocumab) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback